back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2019-06-27 18:16 Tx date 2019-06-25 |
$CORV
Correvio Pharma Corp. |
Corrigan, Mark
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,564,000
+400,000 vol $3.91 each |
1,059,000 | |
| Filed 2019-06-20 16:54 Tx date 2019-06-18 |
$CORV
Correvio Pharma Corp. |
Corrigan, Mark
4 - Director of Issuer
Direct Ownership
|
Options
38 - Redemption, retraction, cancellation, repurchase
|
$-1,564,000
-400,000 vol $3.91 each |
659,000 | |
| Filed 2019-03-20 Tx date 2019-03-15 |
$CORV
Correvio Pharma Corp. |
Corrigan, Mark
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,564,000
+400,000 vol $3.91 each |
1,059,000 | |
| Filed 2019-03-20 Tx date 2019-03-15 |
$CORV
Correvio Pharma Corp. |
Corrigan, Mark
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$2,346,000
+600,000 vol $3.91 each |
659,000 | |
| Filed 2018-08-13 Tx date 2018-08-09 |
$NVLN
Novelion Therapeutics Inc. |
Corrigan, Mark
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+50,000 vol |
59,600 | |
| Filed 2018-06-20 Tx date 2018-06-19 |
$CORV
Correvio Pharma Corp. |
Corrigan, Mark
3 - 10% Security Holder of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$73,600
+20,000 vol $3.68 each |
59,000 | |
| Filed 2018-06-20 Tx date 2018-05-25 |
$CORV
Correvio Pharma Corp. |
Corrigan, Mark
3 - 10% Security Holder of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
39,000 | ||
| Filed 2018-06-20 Tx date 2018-05-25 |
$CORV
Correvio Pharma Corp. |
Corrigan, Mark
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
10,000 | ||
| Filed 2017-08-28 Tx date 2015-06-22 |
$COM
Cardiome Pharma Corp. |
Corrigan, Mark
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-08-28 Tx date 2017-08-25 |
$COM
Cardiome Pharma Corp. |
Corrigan, Mark
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$22,000
+10,000 vol $2.20 each |
10,000 | |
| Filed 2017-08-18 Tx date 2017-08-14 |
$COM
Cardiome Pharma Corp. |
Corrigan, Mark
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$49,000
+12,500 vol $3.92 each |
39,000 | |
| Filed 2017-04-05 Tx date 2017-03-30 |
$NVLN
Novelion Therapeutics Inc. |
Corrigan, Mark
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-04-05 Tx date 2017-03-30 |
$NVLN
Novelion Therapeutics Inc. |
Corrigan, Mark
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+9,600 vol |
||
| Filed 2017-04-05 Tx date 2017-03-30 |
$NVLN
Novelion Therapeutics Inc. |
Corrigan, Mark
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-04-05 Tx date 2017-03-30 |
$NVLN
Novelion Therapeutics Inc. |
Corrigan, Mark
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+9,600 vol |
||
| Filed 2017-04-05 Tx date 2017-03-30 |
$NVLN
Novelion Therapeutics Inc. |
Corrigan, Mark
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
9,600 | ||
| Filed 2016-08-15 Tx date 2016-08-11 |
$COM
Cardiome Pharma Corp. |
Corrigan, Mark
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$38,500
+12,500 vol $3.08 each |
26,500 | |
| Filed 2015-06-26 Tx date 2015-06-22 |
$COM
Cardiome Pharma Corp. |
Corrigan, Mark
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-06-26 Tx date 2015-06-22 |
$COM
Cardiome Pharma Corp. |
Corrigan, Mark
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$163,240
+14,000 vol $11.66 each |
14,000 |